Bringing our experience to the hospital

ratiopharm has set itself the target of entering the European hospital business through its subsidiary ratiopharm direct. Additionally, ratiopharm direct has been founded to show the commitment and focus we have in setting up the European oncology business. The ratiopharm direct portfolio comprises quality oncology generics and - in the future - will include innovative products and biologics.

ratiopharm direct is your new partner in hospitals with the goal of providing an innovative and unique approach through the combination of its portfolio:

We plan to launch up to 20 new molecules in the next 5 years.

Our experience of more than 30 years in the worldwide distribution of medicines provides us with the necessary expertise, knowledge and logistics to ensure the highest standard of service and reliability when we supply products to our customers.